Skip to main content
SpringerLink
Log in

Polyzystisches Ovarsyndrom (PCOS)

  • Chapter
  • First Online:
Reproduktionsmedizin

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Bereits 1721 wurde durch Antonio Vallisneri, einem Mediziner, Wissenschaftler und Naturforscher aus Padua, das polyzystische Ovarsyndrom (PCOS) anhand auffallend großer Ovarien bei einer verheirateten, infertilen Frau beschrieben. 1935 berichteten Stein und Leventhal von Zyklusunregelmäßigkeiten und Hirsutismus bei einer Gruppe von Frauen mit großen sowie mit einer hohen Anzahl an Follikeln versehenen Ovarien. Als Therapie wurde im Jahre 1948 von Stein und Leventhal eine chirurgische Keilresektion am Ovar postuliert, welche in einer Studie zu einer postoperativen Schwangerschaftsrate von 65 % führte. In der Folge wurde das PCOS auch lange als Stein-Leventhal-Syndrom bezeichnet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 289.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Anagnostis P, Tarlatzis BC, Kauffman RP (2017) Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism:pii: S0026-0495(17)30274-3. https://doi.org/10.1016/j.metabol.2017.09.016. [Epub vor Druck] PubMed PMID: 29024702

    Article  CAS  Google Scholar 

  • Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V (2013) Endocrine and clinical effects of myo­inositol administration in poly­ cystic ovary syndrome. A randomized study. Gynecol Endocrinol 29:375–379

    Article  CAS  Google Scholar 

  • Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar- Morreale HF, Futterweit W et al (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91:4237–4245

    Article  CAS  Google Scholar 

  • Azziz R, Dumesic DA, Goodarzi MO (2011) Polycystic ovary syndrome: an ancient disorder? Fertil Steril 95(5):1544–1548. https://doi.org/10.1016/j.fertnstert.2010.09.032. Epub 2010 Oct 27. Review. PubMed PMID:20979996; PubMed Central PMCID: PMC3164771

    Article  PubMed  Google Scholar 

  • Balen AH (2013) Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 373:77–82

    Article  CAS  Google Scholar 

  • Balen AH, Anderson RA (2007) Policy & practice committee of the BFS: impact of obesity on female reproductive health: British fertility society, policy and practice guidelines. Hum Fertil 10:195–206

    Article  Google Scholar 

  • Balen AH, Tan SL, Jacobs HS (1993) Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol 100:1082–1089

    Article  CAS  Google Scholar 

  • Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H (2016) The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 22(6):687–708. Epub 2016 Aug 10. Review. PubMed PMID: 27511809

    Article  Google Scholar 

  • Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748–758. https://doi.org/10.1093/humupd/dmu012. Epub 2014 Mar 30. Review. PubMed PMID: 24688118; PubMed Central PMCID: PMC4326303

    Article  PubMed Central  Google Scholar 

  • Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12(6):673–683. Epub 2006 Aug 4. Review. PubMed PMID: 16891296

    Article  CAS  Google Scholar 

  • Boyle JA, Cunningham J, O’Dea K, Dunbar T, Norman RJ (2012) Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia. Med J Aust 196:62–66

    Article  Google Scholar 

  • Brewer C, Acharya S, Thake F, Tang T, Balen A (2010) Effect of metformin taken in the ‚fresh‘ in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome. Hum Fertil 13(3):134–142. https://doi.org/10.3109/14647273.2010.504805. PubMed PMID: 20849198

    Article  CAS  Google Scholar 

  • Casarini L, Simoni M, Brigante G (2016) Is polycystic ovary syndrome a sexual conflict? A review. Reprod Biomed Online 32(4):350–361. https://doi.org/10.1016/j.rbmo.2016.01.011. Epub 2016 Feb 2. Review. PubMed PMID: 26874987

    Article  PubMed  Google Scholar 

  • Corbett SJ, McMichael AJ, Prentice AM (2009) Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis. Am J Hum Biol 21(5):587–598. https://doi.org/10.1002/ajhb.20937. PubMed PMID: 19533615

    Article  PubMed  Google Scholar 

  • Dahlgren E (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow up. Fertil Steril 57:505–513

    Article  CAS  Google Scholar 

  • Dewailly D, Alebić MŠ, Duhamel A, Stojanović N (2014a) Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles. Hum Reprod. 29(11):2536–2543. https://doi.org/10.1093/humrep/deu242. Epub 2014 Sep 29. PubMed PMID: 25267785

    Article  CAS  Google Scholar 

  • Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA (2014b) The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 20(3):370–385. https://doi.org/10.1093/humupd/dmt062. Epub 2014 Jan 14. Review. Erratum in: Hum Reprod Update. 2014 Sep-Oct;20(5):804. PubMed PMID: 24430863

    Article  PubMed  Google Scholar 

  • Dumont A, Robin G, Catteau-Jonard S, Dewailly D (2015) Role of anti-müllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Rep Biol Endocrinol 13:137. https://doi.org/10.1186/s12958-015-0134-9

    Article  CAS  Google Scholar 

  • ESHRE/ASRM (2008) Thessaloniki sponsored PCOS consensus workshop group consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23:462–477

    Article  Google Scholar 

  • Facchinetti F, Bizzarri M, Benvenga S, D’Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P (2015) Results from the international consensus conference on myo­inositol and dchiro­ inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol 195:72–76

    Article  CAS  Google Scholar 

  • Ferriman DM, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol 21:1440–1447

    Article  CAS  Google Scholar 

  • Franik S, Kremer JA, Nelen WL, Farquhar C (2014) Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev (2):CD010287. https://doi.org/10.1002/14651858.CD010287.pub2. Review. PubMed PMID: 24563180

  • Garg D, Tal R (2016) The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online 33(1):15–28. https://doi.org/10.1016/j.rbmo.2016.04.007. Epub 2016 Apr 21. Review. PubMed PMID: 27174394

    Article  CAS  PubMed  Google Scholar 

  • Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM (2006) GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13:628–638

    Article  CAS  Google Scholar 

  • Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J (2017) Female infertility, infertility-associated diagnoses, and comorbidities: a review. J Assist Reprod Genet 34(2):167–177. https://doi.org/10.1007/s10815-016-0836-8. Epub 2016 Nov 5. Review. PubMed PMID: 27817040; PubMed Central PMCID: PMC5306404

    Article  Google Scholar 

  • Homburg R (2005) Clomiphene citrate – end of an era? A mini-review. Hum Reprod 20:2043–2051

    Google Scholar 

  • Homburg R (2010) Choices in the treatment of anovulatory PCOS. Current management of polycystic ovary syndrome. In: Balen A, Franks S, Homburg R (Hrsg) Proceedings of 59th RCOG study group: current management of polycystic ovary syndrome. RCOG Press, London, S 143–152

    Google Scholar 

  • Koivunen R, Pouta A, Franks S, Martikainen H, Sovio U, Hartikainen AL, McCarthy MI, Ruokonen A, Bloigu A, Järvelin MR, Morin-Papunen L, Northern Finland Birth Cohort 1966 Study (2008) Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. Hum Reprod 23(9):2134–2139. https://doi.org/10.1093/humrep/den136. Epub 2008 Jun 10. PubMed PMID: 18544581

    Article  CAS  Google Scholar 

  • Kousta E, White DM, Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3(4):359–365. Review. PubMed PMID: 9459281

    Article  CAS  Google Scholar 

  • Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe AA (2014) The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Müllerian hormone. Hum Reprod 29(4):791–801. https://doi.org/10.1093/humrep/det469. Epub 2014 Jan 16. PubMed PMID: 24435776

    Article  CAS  Google Scholar 

  • Legro RS (2016) Mr. Fertility authority, tear down that weight wall! Hum Repro 31(12):2662–2664. https://doi.org/10.1093/humrep/dew253

    Article  Google Scholar 

  • Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, Cooperative Multicenter Reproductive Medicine Network (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356(6):551–566. PubMed PMID: 17287476

    Article  CAS  Google Scholar 

  • Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6–15. https://doi.org/10.1016/j.fertnstert.2016.05.003. Epub 2016 May 24. Review. PubMed PMID: 27233760

    Article  Google Scholar 

  • McCartney CR, Marshall JC (2016) CLINICAL PRACTICE. Polycystic ovary syndrome. N Engl J Med 375(1):54–64. https://doi.org/10.1056/NEJMcp1514916. Review. PubMed PMID: 27406348; PubMed Central PMCID: PMC5301909

    Article  PubMed  PubMed Central  Google Scholar 

  • Mellembakken JR, Berga SL, Kilen M, Tanbo TG, Abyholm T, Fedorcsák P (2011) Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome. Hum Reprod 26(9):2499–2504. https://doi.org/10.1093/humrep/der214. Epub 2011 Jun 30. PubMed PMID: 21724569; PubMed Central PMCID: PMC444778

    Article  PubMed  PubMed Central  Google Scholar 

  • Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16(4):347–363. https://doi.org/10.1093/humupd/dmq001. Epub 2010 Feb 16. Review. PubMed PMID: 20159883

    Article  CAS  PubMed  Google Scholar 

  • Mutsaerts MA, van Oers AM, Groen H, Burggraaff JM, Kuchenbecker WK, Perquin DA, Koks CA, van Golde R, Kaaijk EM, Schierbeek JM, Oosterhuis GJ, Broekmans FJ, Bemelmans WJ, Lambalk CB, Verberg MF, van der Veen F, Klijn NF, Mercelina PE, van Kasteren YM, Nap AW, Brinkhuis EA, Vogel NE, Mulder RJ, Gondrie ET, de Bruin JP, Sikkema JM, de Greef MH, ter Bogt NC, Land JA, Mol BW, Hoek A (2016) Randomized trial of a lifestyle program in obese infertile women. N Engl J Med 374(20):1942–1953. https://doi.org/10.1056/NEJMoa1505297. PubMed PMID: 27192672

    Article  CAS  PubMed  Google Scholar 

  • Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ (2015) Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 21:560–574

    Article  CAS  Google Scholar 

  • National Institutes of Health (NIH) (2012) Evidence-based methodology workshop on polycystic ovary syndrome, 03–05.12.2012. Executive summary. https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf. Zugegriffen am 15.11.2017

  • Neumann K, Indorf I, Härtel C, Cirkel C, Rody A, Beyer DA (2017) C-section prevalence among obese mothers and neonatal hypoglycemia: a cohort analysis of the department of gynecology and obstetrics of the University of Lübeck. Geburtshilfe Frauenheilkd 77(5):487–494. https://doi.org/10.1055/s-0043-108763. Epub 2017 May 24. PubMed PMID: 28579620; PubMed Central PMCID: PMC5444529

    Article  Google Scholar 

  • Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC, ESTHER-1 study group (2017) Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril 107(2):387–396.e4. https://doi.org/10.1016/j.fertnstert.2016.10.033. Epub 2016 Nov 29. PubMed PMID: 27912901

    Article  CAS  PubMed  Google Scholar 

  • Oers AM van, Mutsaerts MAQ, Burggraaff JM, Kuchenbecker WKH, Perquin DAM, Koks CAM, van Golde R, Kaaijk EM, Schierbeek JM, Klijn NF, van Kasteren YM, Land JA, Mol BWJ, Hoek A, Groen H, LIFEstyle study group (2017) Cost-effectiveness analysis of lifestyle intervention in obese infertile women. Hum Reprod 32(7):1418-1426. https://doi.org/10.1093/humrep/dex092. PubMed PMID: 28486704

    Article  CAS  Google Scholar 

  • Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC (1998) Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83(2):582–590. PubMed PMID: 9467578

    CAS  PubMed  Google Scholar 

  • Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H (2007) Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92(1):240–245. Epub 2006 Oct 24. PubMed PMID: 17062765

    Article  CAS  Google Scholar 

  • Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N et al (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 33:812–841

    Article  CAS  Google Scholar 

  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25. PubMed PMID: 14711538

    Article  Google Scholar 

  • Stein IF, Leventhal ML (1935) Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191

    Article  Google Scholar 

  • Stein IF, Cohen MR, Elson RE (1948) Results of bilateral ovarian wedge resection in 47 cases of sterility. Am J Obstet Gynecol 58:267–273

    Article  Google Scholar 

  • Ünlütürk U, Sezgin E, Yildiz BO (2016) Evolutionary determinants of polycystic ovarysyndrome: part 1. Fertil Steril 106(1):33–41. https://doi.org/10.1016/j.fertnstert.2016.05.010. Epub 2016 May 26. Review. PubMed PMID: 27238626

    Article  PubMed  Google Scholar 

  • Vallisneri A (1721/1920) Cited in Insler V, Lunesfeld B. Polycystic ovarian disease: a challenge and controversy. Gynecol Endocrinol 4:51–69

    Google Scholar 

  • Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogøy K, Kleggetveit O, Hjelle S, von Brandis P, Eikeland T, Flo K, Berg KF, Bunford G, Lund A, Bjerke C, Almås I, Berg AH, Danielson A, Lahmami G, Carlsen SM (2010) Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95(12):E448–E455. https://doi.org/10.1210/jc.2010-0853. Epub 2010 Oct 6. PubMed PMID: 20926533

    Article  CAS  Google Scholar 

  • Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27:3067–3073

    Article  Google Scholar 

  • Yu HF, Chen HS, Rao DP, Gong J (2016) Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e4863

    Article  CAS  Google Scholar 

  • Zhang J, Li T, Zhou L, Tang L, Xu L, Wu T, Lim DC (2010) Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. Cochrane Database Syst Rev (9):CD007535. https://doi.org/10.1002/14651858.CD007535.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 12;10: CD007535. PubMed PMID: 20824862

Download references

Author information

Authors and Affiliations

  1. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland

    Kay Neumann

  2. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Schleswig-Holstein – Campus Lübeck, Lübeck, Deutschland

    Georg Griesinger

Authors
  1. Kay Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georg Griesinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kay Neumann .

Editor information

Editors and Affiliations

  1. Facharzt-Zentrum für Kinderwunsch Pränatale Medizin, Endokrinologie und Osteologie Hamburg GmbH, amedes experts, Hamburg, Germany

    Klaus Diedrich

  2. SYNLAB Holding Deutschland GmbH, Augsburg, Germany

    Michael Ludwig

  3. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Schleswig-Holstein – Campus Lübeck, Lübeck, Germany

    Georg Griesinger

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Neumann, K., Griesinger, G. (2020). Polyzystisches Ovarsyndrom (PCOS). In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57636-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57636-6_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57635-9

  • Online ISBN: 978-3-662-57636-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation